Hugo Cerecetto

9.3k total citations · 1 hit paper
300 papers, 7.9k citations indexed

About

Hugo Cerecetto is a scholar working on Organic Chemistry, Epidemiology and Molecular Biology. According to data from OpenAlex, Hugo Cerecetto has authored 300 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Organic Chemistry, 86 papers in Epidemiology and 70 papers in Molecular Biology. Recurrent topics in Hugo Cerecetto's work include Synthesis and Biological Evaluation (118 papers), Trypanosoma species research and implications (82 papers) and Research on Leishmaniasis Studies (52 papers). Hugo Cerecetto is often cited by papers focused on Synthesis and Biological Evaluation (118 papers), Trypanosoma species research and implications (82 papers) and Research on Leishmaniasis Studies (52 papers). Hugo Cerecetto collaborates with scholars based in Uruguay, Spain and Argentina. Hugo Cerecetto's co-authors include Mercedes González, Dinorah Gambino, Williams Porcal, Claudio Olea‐Azar, Lucı́a Boiani, Alejandra Gerpe, Gabriela Aguirre, María Laura Lavaggi, Oscar E. Piro and Antonio Monge and has published in prestigious journals such as Chemical Reviews, Blood and PLoS ONE.

In The Last Decade

Hugo Cerecetto

291 papers receiving 7.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology

2024 153 citations Hugo Cerecetto, Clara Viñas et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hugo Cerecetto Uruguay	47	4.8k	1.9k	1.6k	1.5k	1.2k	300	7.9k
Mercedes González Uruguay	48	4.7k 1.0×	1.9k 1.0×	1.5k 1.0×	1.4k 0.9×	1.2k 1.0×	271	8.1k
Glaucius Oliva Brazil	40	1.6k 0.3×	853 0.5×	3.0k 1.9×	940 0.6×	723 0.6×	205	6.6k
Christophe Biot France	50	4.4k 0.9×	537 0.3×	2.2k 1.4×	880 0.6×	1.9k 1.5×	131	6.6k
Susan A. Charman Australia	46	2.2k 0.5×	741 0.4×	2.2k 1.4×	1.8k 1.3×	758 0.6×	152	7.6k
Dinorah Gambino Uruguay	39	2.5k 0.5×	830 0.4×	700 0.4×	537 0.4×	2.4k 1.9×	138	5.0k
Vinod K. Tiwari India	41	4.0k 0.8×	397 0.2×	3.1k 2.0×	429 0.3×	243 0.2×	233	6.8k
Maurizio Botta Italy	54	5.7k 1.2×	818 0.4×	5.5k 3.5×	259 0.2×	1.1k 0.9×	436	11.9k
Christian Bailly France	66	5.6k 1.2×	731 0.4×	10.6k 6.7×	459 0.3×	3.1k 2.5×	520	17.4k
Dharmarajan Sriram India	54	10.0k 2.1×	704 0.4×	4.6k 2.9×	257 0.2×	1.1k 0.9×	440	13.5k
Xinyong Liu China	48	3.9k 0.8×	2.0k 1.0×	2.9k 1.8×	293 0.2×	423 0.3×	341	9.2k

Countries citing papers authored by Hugo Cerecetto

Since Specialization

Citations

This map shows the geographic impact of Hugo Cerecetto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Cerecetto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Cerecetto more than expected).

Fields of papers citing papers by Hugo Cerecetto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo Cerecetto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Cerecetto. The network helps show where Hugo Cerecetto may publish in the future.

Co-authorship network of co-authors of Hugo Cerecetto

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo Cerecetto. A scholar is included among the top collaborators of Hugo Cerecetto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo Cerecetto. Hugo Cerecetto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benítez, Diego, et al.. (2025). Looking for approved-medicines to be repositioned as anti-Trypanosoma cruzi agents. Identification of new chemotypes with good individual- or in combination-biological behaviours. Memórias do Instituto Oswaldo Cruz. 120. e240183–e240183.

Cerecetto, Hugo, Jorge Gil, Lucía Pareja, et al.. (2023). In vitro and in vivo studies on a group of chalcones find promising results as potential drugs against fascioliasis. Experimental Parasitology. 255. 108628–108628. 1 indexed citations

Moreno, María, et al.. (2023). Aptamer-Based Immunotheranostic Strategies. Cancer Biotherapy and Radiopharmaceuticals. 38(4). 246–255. 6 indexed citations

Machado, Camila Maria Longo, Camila de Godoi Carneiro, Mara de Souza Junqueira, et al.. (2023). 99mTc-HYNIC/Cy7-Fab(Bevacizumab): su empleo como agente de imagen en mieloma múltiple. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 42(1). e302–e302.

Aguilera, Elena, Leticia Pérez‐Díaz, Elva Serna, et al.. (2022). Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease. Pharmaceuticals. 16(1). 20–20. 1 indexed citations

Machado, Camila Maria Longo, Camila de Godoi Carneiro, Mara de Souza Junqueira, et al.. (2021). 99mTechnetium- or Cy7-Labeled Fab(Tocilizumab) as Potential Multiple Myeloma Imaging Agents. Anti-Cancer Agents in Medicinal Chemistry. 21(14). 1883–1893. 5 indexed citations

Medeiros, Andrea, Diego Benítez, Marcelo A. Comini, et al.. (2020). New Pd–Fe ferrocenyl antiparasitic compounds with bioactive 8-hydroxyquinoline ligands: a comparative study with their Pt–Fe analogues. Dalton Transactions. 50(5). 1651–1665. 14 indexed citations

Couto, Marcos, María Jesús García García, Mariángeles Kovacs, et al.. (2020). Closo-Carboranyl- and Metallacarboranyl [1,2,3]triazolyl-Decorated Lapatinib-Scaffold for Cancer Therapy Combining Tyrosine Kinase Inhibition and Boron Neutron Capture Therapy. Cells. 9(6). 1408–1408. 29 indexed citations

Ibarra, Manuel, et al.. (2020). Sgc8-c Aptamer as a Potential Theranostic Agent for Hemato-Oncological Malignancies. Cancer Biotherapy and Radiopharmaceuticals. 35(4). 262–270. 22 indexed citations

10.

García, María Fernanda, Mariángeles Kovacs, Emiliano Trías, et al.. (2020). Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-β, Exhibits Powerful In Vivo Anti-Glioblastoma Activity. Cancers. 12(11). 3423–3423. 23 indexed citations

11.

Cassina, Adriana, et al.. (2018). Inhibition of LDL oxidation and inflammasome assembly by nitroaliphatic derivatives. Potential use as anti-inflammatory and anti-atherogenic agents. European Journal of Medicinal Chemistry. 159. 178–186. 4 indexed citations

12.

Varela, Javier, Paula Faral‐Tello, Carlos Robello, et al.. (2017). Identification of New Anti-Trypanosoma Cruzi Agents in Some Uruguayan Plants by NMR-Based Metabolomic Profiling. 2(2). 2 indexed citations

13.

García, María Fernanda, Marcelo Fernández, Hugo Cerecetto, et al.. (2017). 99mTc-HYNIC-Fab(Bevacizumab): potencial agente de imagen para diagnóstico de Linfoma No Hodgkin. 36(2). 1 indexed citations

14.

Couto, Marcos, Mauricio Cabrera, Pablo Cabral, et al.. (2017). Small‐Molecule Kinase‐Inhibitors‐Loaded Boron Cluster as Hybrid Agents for Glioma‐Cell‐Targeting Therapy. Chemistry - A European Journal. 23(39). 9233–9238. 52 indexed citations

15.

Álvarez, Guzmán, Cathia Coronel, Elena Aguilera, et al.. (2017). Multi-Anti-Parasitic Activity of Arylidene Ketones and Thiazolidene Hydrazines against Trypanosoma cruzi and Leishmania spp.. Molecules. 22(5). 709–709. 23 indexed citations

16.

Cerecetto, Hugo, et al.. (2013). 低酸素症画像化のための有望な薬剤としての2種の新規 68 Ga標識5-ニトロイミダゾール誘導体の合成,in vitroおよびin vivoキャラクタリゼーション. Nuclear Medicine and Biology. 40(2). 273–279. 12 indexed citations

17.

Cajarville, Cecilia, et al.. (2013). Anaerobic Biotransformation ofN-oxide Containing Aromatic Heterocycles by Bovine Ruminal Fluid. Revista Virtual de Química. 5(6). 2 indexed citations

18.

Giglio, Javier, Soledad Fernández, Ana Rey, & Hugo Cerecetto. (2010). Synthesis and biological characterisation of novel dithiocarbamate containing 5-nitroimidazole 99mTc-complexes as potential agents for targeting hypoxia. Bioorganic & Medicinal Chemistry Letters. 21(1). 394–397. 33 indexed citations

19.

López, Gloria V., Paola Hernández, Ana M. Ferreira, et al.. (2007). Second generation of α-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization. Bioorganic & Medicinal Chemistry. 15(18). 6262–6272. 23 indexed citations

20.

Teixeira, Letícia R., Alzir A. Batista, A.S. Mangrich, et al.. (2007). 4-Nitroacetophenone-derived thiosemicarbazones and their copper(II) complexes with significant in vitro anti-trypanosomal activity. European Journal of Medicinal Chemistry. 43(5). 939–948. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact